Canada markets close in 3 hours 12 minutes

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.65000.0000 (0.00%)
As of 12:27PM EDT. Market open.

Insider Transactions

Currency in USD
Insider Purchases Last 6 MonthsSharesTrans
Purchases00
SalesN/A0
Net Shares Purchased (Sold)00
Total Insider Shares Held9.14MN/A
% Net Shares Purchased (Sold)N/AN/A
Net Institutional Purchases Prior Quarter to Latest QuarterShares
Net Shares Purchased (Sold)N/A
% Change in Institutional Shares HeldN/A

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDateShares

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectMar 28, 20249,956

ROBINSON CHANDLER D
Chief Executive Officer

DirectMar 28, 202424,474

CITTADINE ANDREW
Chief Operating Officer

DirectMar 28, 20248,952

STARR CHRISTOPHER M
Director

DirectDec 29, 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectDec 29, 202311,188

ANDERSON RAYMOND WILLIAM
Director

DirectDec 29, 20232,533

KLAUSNER ARTHUR J
Director

DirectDec 29, 20232,533

BROWN MICHAEL J
Director

DirectDec 29, 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

DirectDec 29, 202331,198

CITTADINE ANDREW
Chief Operating Officer

DirectDec 29, 20238,952

STARR CHRISTOPHER M
Director

DirectSept 29, 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectSept 29, 20239,956

ANDERSON RAYMOND WILLIAM
Director

DirectSept 29, 20232,533

KLAUSNER ARTHUR J
Director

DirectSept 29, 20232,533

BROWN MICHAEL J
Director

DirectSept 29, 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

DirectSept 29, 202324,474

CITTADINE ANDREW
Chief Operating Officer

DirectSept 29, 20238,953

STARR CHRISTOPHER M
Director

DirectJun 30, 20232,534

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectJun 30, 202314,846

ANDERSON RAYMOND WILLIAM
Director

DirectJun 30, 20232,534

KLAUSNER ARTHUR J
Director

DirectJun 30, 20232,534

BROWN MICHAEL J
Director

DirectJun 30, 20232,534

ROBINSON CHANDLER D
Chief Executive Officer

DirectJun 30, 202335,039

CITTADINE ANDREW
Chief Operating Officer

DirectJun 30, 202313,841

STARR CHRISTOPHER M
Director

DirectMar 31, 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectMar 31, 20235,067

ANDERSON RAYMOND WILLIAM
Director

DirectMar 31, 20232,533

KLAUSNER ARTHUR J
Director

DirectMar 31, 20232,533

BROWN MICHAEL J
Director

DirectMar 31, 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

DirectMar 31, 202313,911

CITTADINE ANDREW
Chief Operating Officer

DirectMar 31, 20234,063

STARR CHRISTOPHER M
Director

DirectDec 30, 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectDec 30, 20226,297

ANDERSON RAYMOND WILLIAM
Director

DirectDec 30, 20222,859

KLAUSNER ARTHUR J
Director

DirectDec 30, 20222,859

BROWN MICHAEL J
Director

DirectDec 30, 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

DirectDec 30, 202220,635

CITTADINE ANDREW
Chief Operating Officer

DirectDec 30, 20224,062

CITTADINE ANDREW
Chief Operating Officer

Purchase at price 3.00 - 3.15 per share.Direct49,659Nov 15, 202216,053

STARR CHRISTOPHER M
Director

DirectSept 30, 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectSept 30, 20225,066

ANDERSON RAYMOND WILLIAM
Director

DirectSept 30, 20222,859

KLAUSNER ARTHUR J
Director

DirectSept 30, 20222,859

BROWN MICHAEL J
Director

DirectSept 30, 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

DirectSept 30, 202213,911

CITTADINE ANDREW
Chief Operating Officer

DirectSept 30, 20224,063

STARR CHRISTOPHER M
Director

DirectJun 30, 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectJun 30, 20228,913

ANDERSON RAYMOND WILLIAM
Director

DirectJun 30, 20222,859

KLAUSNER ARTHUR J
Director

DirectJun 30, 20222,859

BROWN MICHAEL J
Director

DirectJun 30, 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

DirectJun 30, 202223,882

CITTADINE ANDREW
Chief Operating Officer

DirectJun 30, 20228,125

STARR CHRISTOPHER M
Director

DirectMar 31, 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectMar 31, 20221,221

ANDERSON RAYMOND WILLIAM
Director

DirectMar 31, 20222,859

KLAUSNER ARTHUR J
Director

DirectMar 31, 20222,859

BROWN MICHAEL J
Director

DirectMar 31, 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

DirectMar 31, 20223,941

MAZAR ANDREW PAUL
Officer and Director

DirectMar 31, 20221,606

STARR CHRISTOPHER M
Director

DirectDec 31, 2021751

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectDec 31, 20211,221

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectDec 31, 20211,231

ANDERSON RAYMOND WILLIAM
Director

DirectDec 31, 2021751

KLAUSNER ARTHUR J
Director

DirectDec 31, 2021751

BROWN MICHAEL J
Director

DirectDec 31, 2021751

ROBINSON CHANDLER D
Chief Executive Officer

DirectDec 31, 20213,941

ROBINSON CHANDLER D
Chief Executive Officer

DirectDec 31, 20216,724

MAZAR ANDREW PAUL
Officer and Director

DirectDec 31, 20211,606

MAZAR ANDREW PAUL
Officer and Director

DirectDec 31, 20211,937

STARR CHRISTOPHER M
Director

DirectSept 30, 2021751

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectSept 30, 20211,221

ANDERSON RAYMOND WILLIAM
Director

DirectSept 30, 2021751

KLAUSNER ARTHUR J
Director

DirectSept 30, 2021751

BROWN MICHAEL J
Director

DirectSept 30, 2021751

ROBINSON CHANDLER D
Chief Executive Officer

DirectSept 30, 20213,941

MAZAR ANDREW PAUL
Officer and Director

DirectSept 30, 20211,606

STARR CHRISTOPHER M
Director

DirectJun 30, 2021752

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectJun 30, 20212,442

ANDERSON RAYMOND WILLIAM
Director

DirectJun 30, 2021752

KLAUSNER ARTHUR J
Director

DirectJun 30, 2021752

BROWN MICHAEL J
Director

DirectJun 30, 2021752

ROBINSON CHANDLER D
Chief Executive Officer

DirectJun 30, 20217,883

MAZAR ANDREW PAUL
Officer and Director

DirectJun 30, 20213,212

STARR CHRISTOPHER M
Director

DirectMar 31, 2021751

ANDERSON RAYMOND WILLIAM
Director

DirectMar 31, 2021751

KLAUSNER ARTHUR J
Director

DirectMar 31, 2021751

BROWN MICHAEL J
Director

DirectMar 31, 2021751

TACTIC PHARMA, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.60 per share.Indirect1,325,000Feb 11, 2021125,000

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

DirectJan 01, 20211,231

ROBINSON CHANDLER D
Chief Executive Officer

DirectJan 01, 20216,724

MAZAR ANDREW PAUL
Officer and Director

DirectJan 01, 20211,937

STARR CHRISTOPHER M
Director

DirectDec 31, 2020644

ANDERSON RAYMOND WILLIAM
Director

DirectDec 31, 2020644

KLAUSNER ARTHUR J
Director

DirectDec 31, 2020644

BROWN MICHAEL J
Director

DirectDec 31, 2020644

STARR CHRISTOPHER M
Director

DirectJun 30, 2020323

ANDERSON RAYMOND WILLIAM
Director

DirectJun 30, 2020323

KLAUSNER ARTHUR J
Director

DirectJun 30, 2020323

BROWN MICHAEL J
Director

DirectJun 30, 2020323

STARR CHRISTOPHER M
Director

DirectMar 31, 2020322

ANDERSON RAYMOND WILLIAM
Director

DirectMar 31, 2020322

KLAUSNER ARTHUR J
Director

DirectMar 31, 2020322

BROWN MICHAEL J
Director

DirectMar 31, 2020322

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Purchase at price 8.00 per share.Direct2,600Dec 18, 2019325

LEO KARL
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect1,252,510Dec 18, 2019156,564

HENDRICKS DIANE
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect3,750,000Dec 18, 2019468,750

TACTIC PHARMA, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect1,000,000Dec 18, 2019125,000

RIOUX PATRICE P
Officer

Conversion of Exercise of derivative security at price 0.00 - 6.00 per share.Direct109,998Nov 26, 201918,433